Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

HKG:2591 Statistics

Total Valuation

HKG:2591 has a market cap or net worth of HKD 6.08 billion. The enterprise value is 4.92 billion.

Market Cap	6.08B
Enterprise Value	4.92B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2591 has 456.82 million shares outstanding. The number of shares has increased by 3.44% in one year.

Current Share Class	420.29M
Shares Outstanding	456.82M
Shares Change (YoY)	+3.44%
Shares Change (QoQ)	+6.58%
Owned by Insiders (%)	10.12%
Owned by Institutions (%)	46.86%
Float	246.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	41.55
PB Ratio	5.19
P/TBV Ratio	5.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.96
EV / Sales	33.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.03

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.16.

Current Ratio	2.93
Quick Ratio	2.67
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-202.02

Financial Efficiency

Return on equity (ROE) is -36.91% and return on invested capital (ROIC) is -21.40%.

Return on Equity (ROE)	-36.91%
Return on Assets (ROA)	-17.30%
Return on Invested Capital (ROIC)	-21.40%
Return on Capital Employed (ROCE)	-32.53%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	758,262
Profits Per Employee	-1.97M
Employee Count	193
Asset Turnover	0.10
Inventory Turnover	0.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	20.90
200-Day Moving Average	n/a
Relative Strength Index (RSI)	23.43
Average Volume (20 Days)	945,350

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2591 had revenue of HKD 146.34 million and -379.87 million in losses. Loss per share was -0.88.

Revenue	146.34M
Gross Profit	130.26M
Operating Income	-386.00M
Pretax Income	-379.87M
Net Income	-379.87M
EBITDA	-378.03M
EBIT	-386.00M
Loss Per Share	-0.88

Balance Sheet

The company has 1.34 billion in cash and 185.01 million in debt, with a net cash position of 1.16 billion or 2.53 per share.

Cash & Cash Equivalents	1.34B
Total Debt	185.01M
Net Cash	1.16B
Net Cash Per Share	2.53
Equity (Book Value)	1.17B
Book Value Per Share	2.57
Working Capital	1.08B

Cash Flow

In the last 12 months, operating cash flow was -328.87 million and capital expenditures -22.22 million, giving a free cash flow of -351.10 million.

Operating Cash Flow	-328.87M
Capital Expenditures	-22.22M
Depreciation & Amortization	8.24M
Net Borrowing	159.24M
Free Cash Flow	-351.10M
FCF Per Share	-0.77

Margins

Gross margin is 89.01%, with operating and profit margins of -263.76% and -259.57%.

Gross Margin	89.01%
Operating Margin	-263.76%
Pretax Margin	-259.57%
Profit Margin	-259.57%
EBITDA Margin	-258.32%
EBIT Margin	-263.76%
FCF Margin	n/a

Dividends & Yields

HKG:2591 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.44%
Shareholder Yield	-3.44%
Earnings Yield	-6.25%
FCF Yield	-5.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2591 has an Altman Z-Score of 17.06 and a Piotroski F-Score of 1.

Altman Z-Score	17.06
Piotroski F-Score	1